Shaheen A Farhadi

Title: Shaheen A Farhadi: Innovator in Targeted Effector Proteins

Introduction

Shaheen A Farhadi is a prominent inventor based in Gainesville, FL (US). She has made significant contributions to the field of biotechnology, particularly in the development of targeted effector proteins. With a total of 2 patents, her work is paving the way for advancements in pharmaceutical formulations.

Latest Patents

Farhadi's latest patents include "TARGETED CHONDROITINASE ABC FUSION PROTEINS AND COMPLEXES THEREOF" and "Targeted effector proteins and uses thereof." These patents describe targeted effector fusion proteins that can be linked to a targeting moiety. The monomer targeted effector fusion proteins can form both homogeneous and heterogeneous complexes. Furthermore, these proteins and their complexes can be formulated as pharmaceutical formulations, which can be administered to subjects in need.

Career Highlights

Shaheen A Farhadi is associated with the University of Florida Research Foundation Inc., where she continues to innovate and contribute to her field. Her research focuses on the intersection of biotechnology and medicine, aiming to improve therapeutic outcomes through targeted protein delivery.

Collaborations

Farhadi collaborates with notable colleagues, including Benjamin George Keselowsky and Dillon T Seroski. These partnerships enhance her research capabilities and foster innovation in her projects.

Conclusion

Shaheen A Farhadi is a trailblazer in the field of targeted effector proteins, with her patents reflecting her commitment to advancing medical science. Her work at the University of Florida Research Foundation Inc. continues to inspire future innovations in biotechnology.